Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma

Fig. 2

Visual nomogram of the clinical + radiomic Cox model in predicting 3- and 5-year PFS. Note: EBV-DNA, Epstein-Barr virus DNA (0, < 1000 copies/ml; 1, ≥1000 copies/ml). Nomogram is used: First, all predictor nodes can be found on the “node” line (EBV-DNA < 1000 copies/ml is rated 0 point, and EBV-DNA ≥ 1000 copies/ml 7.5 points; overall stage 3 is rated 0 point, and the overall stage 4 3.0 points; stage T1 is rated 0 points, stage T2 2.0 points, stage T3 4.0 points, and T4 6.0 points, and so on) . Then ten predicted nodes are added to the “total score” row. Finally, a vertical line was plotted down from the “total score” to the “3- or 5-year survival rate” axis

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us